Alessio Nencioni
Room 221
Department of Internal Medicine
University of Genoa
V.le Benedetto XV 6
Italy
Name/email consistency: high
- Synthetic lethality-based therapeutics: perspectives for applications in colorectal cancer. Soncini, D., Caffa, I., Patrone, F., Ballestrero, A., Nencioni, A. Curr. Cancer. Drug. Targets (2012)
- Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression. Nencioni, A., Cea, M., Garuti, A., Passalacqua, M., Raffaghello, L., Soncini, D., Moran, E., Zoppoli, G., Pistoia, V., Patrone, F., Ballestrero, A. PLoS. ONE (2010)
- Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. Nencioni, A., Garuti, A., Schwarzenberg, K., Cirmena, G., Dal Bello, G., Rocco, I., Barbieri, E., Brossart, P., Patrone, F., Ballestrero, A. Eur. J. Immunol. (2006)
- Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis. Nencioni, A., Hua, F., Dillon, C.P., Yokoo, R., Scheiermann, C., Cardone, M.H., Barbieri, E., Rocco, I., Garuti, A., Wesselborg, S., Belka, C., Brossart, P., Patrone, F., Ballestrero, A. Blood (2005)
- Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells. Nencioni, A., Wille, L., Dal Bello, G., Boy, D., Cirmena, G., Wesselborg, S., Belka, C., Brossart, P., Patrone, F., Ballestrero, A. Clin. Cancer Res. (2005)